
### [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759)
**Label:** B-cell non-Hodgkin lymphoma

**Subclasses:** [MONDO:0018225](http://purl.obolibrary.org/obo/MONDO_0018225) (ALK-positive large b-cell lymphoma), [MONDO:0018621](http://purl.obolibrary.org/obo/MONDO_0018621) (lymphoplasmacytic lymphoma without IgM production), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0006119](http://purl.obolibrary.org/obo/MONDO_0006119) (breast mucosa-associated lymphoid tissue lymphoma), [MONDO:0006117](http://purl.obolibrary.org/obo/MONDO_0006117) (breast diffuse large b-cell lymphoma), [MONDO:0006158](http://purl.obolibrary.org/obo/MONDO_0006158) (colorectal diffuse large b-cell lymphoma), [MONDO:0006430](http://purl.obolibrary.org/obo/MONDO_0006430) (splenic mantle cell lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0006150](http://purl.obolibrary.org/obo/MONDO_0006150) (colon Burkitt lymphoma), [MONDO:0017600](http://purl.obolibrary.org/obo/MONDO_0017600) (hairy cell leukemia variant), [MONDO:0019469](http://purl.obolibrary.org/obo/MONDO_0019469) (T-cell large granular lymphocyte leukemia), [MONDO:0017601](http://purl.obolibrary.org/obo/MONDO_0017601) (diffuse large b-cell lymphoma with chronic inflammation), [MONDO:0019465](http://purl.obolibrary.org/obo/MONDO_0019465) (Nodal marginal zone b-cell lymphoma), [MONDO:0013088](http://purl.obolibrary.org/obo/MONDO_0013088) (FL1), [MONDO:0019466](http://purl.obolibrary.org/obo/MONDO_0019466) (lymphomatoid granulomatosis), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (B-cell chronic lymphocytic leukemia), [MONDO:0019461](http://purl.obolibrary.org/obo/MONDO_0019461) (b-cell prolymphocytic leukemia), [MONDO:0004947](http://purl.obolibrary.org/obo/MONDO_0004947) (b-cell acute lymphoblastic leukemia), [MONDO:0019462](http://purl.obolibrary.org/obo/MONDO_0019462) (splenic marginal zone lymphoma), [MONDO:0000901](http://purl.obolibrary.org/obo/MONDO_0000901) (relapsed/refractory diffuse large B-cell lymphoma), [MONDO:0004104](http://purl.obolibrary.org/obo/MONDO_0004104) (splenic manifestation of hairy cell leukemia), [MONDO:0007897](http://purl.obolibrary.org/obo/MONDO_0007897) (leukemia, chronic lymphocytic), [MONDO:0007650](http://purl.obolibrary.org/obo/MONDO_0007650) (MALT lymphoma), [MONDO:0002083](http://purl.obolibrary.org/obo/MONDO_0002083) (Richter's syndrome), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), [MONDO:0012318](http://purl.obolibrary.org/obo/MONDO_0012318) (leukemia, chronic lymphocytic, susceptibility to, 1), [MONDO:0018813](http://purl.obolibrary.org/obo/MONDO_0018813) (high grade b-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement), [MONDO:0018935](http://purl.obolibrary.org/obo/MONDO_0018935) (hairy cell leukemia), [MONDO:0007190](http://purl.obolibrary.org/obo/MONDO_0007190) (leukemia, chronic lymphocytic, susceptibility to, 2), [MONDO:0017599](http://purl.obolibrary.org/obo/MONDO_0017599) (splenic diffuse red pulp small b-cell lymphoma), [MONDO:0018842](http://purl.obolibrary.org/obo/MONDO_0018842) (primary effusion lymphoma), [MONDO:0001607](http://purl.obolibrary.org/obo/MONDO_0001607) (intrapelvic lymph node leukemic reticuloendotheliosis), [MONDO:0017596](http://purl.obolibrary.org/obo/MONDO_0017596) (diffuse large B-cell lymphoma of the central nervous system), [MONDO:0014241](http://purl.obolibrary.org/obo/MONDO_0014241) (leukemia, acute lymphoblastic, susceptibility to, 3), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive B-cell non-Hodgkin lymphoma), [MONDO:0017597](http://purl.obolibrary.org/obo/MONDO_0017597) (T-cell/histiocyte rich large B cell lymphoma), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent B-cell non-Hodgkin lymphoma), [MONDO:0020323](http://purl.obolibrary.org/obo/MONDO_0020323) (primary mediastinal large b-cell lymphoma), [MONDO:0020324](http://purl.obolibrary.org/obo/MONDO_0020324) (intravascular large b-cell lymphoma), [MONDO:0006417](http://purl.obolibrary.org/obo/MONDO_0006417) (small intestinal diffuse large b-cell lymphoma), [MONDO:0003864](http://purl.obolibrary.org/obo/MONDO_0003864) (CLL/SLL), [MONDO:0006416](http://purl.obolibrary.org/obo/MONDO_0006416) (small intestinal Burkitt lymphoma), [MONDO:0004478](http://purl.obolibrary.org/obo/MONDO_0004478) (pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0004110](http://purl.obolibrary.org/obo/MONDO_0004110) (refractory hairy cell leukemia), [MONDO:0004152](http://purl.obolibrary.org/obo/MONDO_0004152) (postgerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma), [MONDO:0015814](http://purl.obolibrary.org/obo/MONDO_0015814) (primary cutaneous follicle center lymphoma), [MONDO:0015813](http://purl.obolibrary.org/obo/MONDO_0015813) (primary cutaneous marginal zone b-cell lymphoma), [MONDO:0017347](http://purl.obolibrary.org/obo/MONDO_0017347) (Plasmablastic lymphoma), [MONDO:0017346](http://purl.obolibrary.org/obo/MONDO_0017346) (Epstein-Barr virus-positive diffuse large b-cell lymphoma of the elderly), [MONDO:0018876](http://purl.obolibrary.org/obo/MONDO_0018876) (mantle cell lymphoma), [MONDO:0012491](http://purl.obolibrary.org/obo/MONDO_0012491) (WM2), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0006428](http://purl.obolibrary.org/obo/MONDO_0006428) (splenic diffuse large b-cell lymphoma), [MONDO:0006226](http://purl.obolibrary.org/obo/MONDO_0006226) (gastric mucosa-associated lymphoid tissue lymphoma), [MONDO:0012936](http://purl.obolibrary.org/obo/MONDO_0012936) (leukemia, chronic lymphocytic, susceptibility to, 5), [MONDO:0006225](http://purl.obolibrary.org/obo/MONDO_0006225) (gastric mantle cell lymphoma), [MONDO:0006268](http://purl.obolibrary.org/obo/MONDO_0006268) (liver diffuse large B-cell lymphoma), [MONDO:0006223](http://purl.obolibrary.org/obo/MONDO_0006223) (gastric diffuse large b-cell lymphoma), [MONDO:0006387](http://purl.obolibrary.org/obo/MONDO_0006387) (primary pulmonary diffuse large b-cell lymphoma), [MONDO:0006420](http://purl.obolibrary.org/obo/MONDO_0006420) (small intestinal mucosa-associated lymphoid tissue lymphoma), [MONDO:0006464](http://purl.obolibrary.org/obo/MONDO_0006464) (thyroid gland mucosa-associated lymphoid tissue lymphoma), [MONDO:0006462](http://purl.obolibrary.org/obo/MONDO_0006462) (thyroid gland diffuse large b-cell lymphoma), [MONDO:0006383](http://purl.obolibrary.org/obo/MONDO_0006383) (primary cutaneous diffuse large B-cell lymphoma, leg type), [MONDO:0012935](http://purl.obolibrary.org/obo/MONDO_0012935) (leukemia, chronic lymphocytic, susceptibility to, 4), [MONDO:0012934](http://purl.obolibrary.org/obo/MONDO_0012934) (leukemia, chronic lymphocytic, susceptibility to, 3), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0007254](http://purl.obolibrary.org/obo/GO_0007254) (JNK cascade), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:1900017](http://purl.obolibrary.org/obo/GO_1900017) (positive regulation of cytokine production involved in inflammatory response), [GO:0060005](http://purl.obolibrary.org/obo/GO_0060005) (vestibular reflex), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0002238](http://purl.obolibrary.org/obo/GO_0002238) (response to molecule of fungal origin), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0050671](http://purl.obolibrary.org/obo/GO_0050671) (positive regulation of lymphocyte proliferation), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:0032204](http://purl.obolibrary.org/obo/GO_0032204) (regulation of telomere maintenance), [GO:0009682](http://purl.obolibrary.org/obo/GO_0009682) (induced systemic resistance), [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production), [GO:0060118](http://purl.obolibrary.org/obo/GO_0060118) (vestibular receptor cell development), [GO:0000987](http://purl.obolibrary.org/obo/GO_0000987) (proximal promoter sequence-specific DNA binding), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0045656](http://purl.obolibrary.org/obo/GO_0045656) (negative regulation of monocyte differentiation), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0021670](http://purl.obolibrary.org/obo/GO_0021670) (lateral ventricle development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0006848](http://purl.obolibrary.org/obo/GO_0006848) (pyruvate transport), [GO:0044330](http://purl.obolibrary.org/obo/GO_0044330) (canonical Wnt signaling pathway involved in positive regulation of wound healing), [GO:0032675](http://purl.obolibrary.org/obo/GO_0032675) (regulation of interleukin-6 production), [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0044337](http://purl.obolibrary.org/obo/GO_0044337) (canonical Wnt signaling pathway involved in positive regulation of apoptotic process), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0002218](http://purl.obolibrary.org/obo/GO_0002218) (activation of innate immune response), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0060252](http://purl.obolibrary.org/obo/GO_0060252) (positive regulation of glial cell proliferation), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0007007](http://purl.obolibrary.org/obo/GO_0007007) (inner mitochondrial membrane organization), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0002904](http://purl.obolibrary.org/obo/GO_0002904) (positive regulation of B cell apoptotic process), [GO:0070976](http://purl.obolibrary.org/obo/GO_0070976) (TIR domain binding), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0032494](http://purl.obolibrary.org/obo/GO_0032494) (response to peptidoglycan), [GO:0034672](http://purl.obolibrary.org/obo/GO_0034672) (anterior/posterior pattern specification involved in pronephros development), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0090096](http://purl.obolibrary.org/obo/GO_0090096) (positive regulation of metanephric cap mesenchymal cell proliferation), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:2001022](http://purl.obolibrary.org/obo/GO_2001022) (positive regulation of response to DNA damage stimulus), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0042101](http://purl.obolibrary.org/obo/GO_0042101) (T cell receptor complex), [GO:0051973](http://purl.obolibrary.org/obo/GO_0051973) (positive regulation of telomerase activity), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:1903862](http://purl.obolibrary.org/obo/GO_1903862) (positive regulation of oxidative phosphorylation), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0042474](http://purl.obolibrary.org/obo/GO_0042474) (middle ear morphogenesis), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0006865](http://purl.obolibrary.org/obo/GO_0006865) (amino acid transport), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0070935](http://purl.obolibrary.org/obo/GO_0070935) (3'-UTR-mediated mRNA stabilization), [GO:0140052](http://purl.obolibrary.org/obo/GO_0140052) (cellular response to oxidised low-density lipoprotein particle stimulus), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0046722](http://purl.obolibrary.org/obo/GO_0046722) (lactic acid secretion), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0060337](http://purl.obolibrary.org/obo/GO_0060337) (type I interferon signaling pathway), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade), [GO:0070491](http://purl.obolibrary.org/obo/GO_0070491) (repressing transcription factor binding), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0045080](http://purl.obolibrary.org/obo/GO_0045080) (positive regulation of chemokine biosynthetic process), [GO:0008063](http://purl.obolibrary.org/obo/GO_0008063) (Toll signaling pathway), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0002082](http://purl.obolibrary.org/obo/GO_0002082) (regulation of oxidative phosphorylation), [GO:2001171](http://purl.obolibrary.org/obo/GO_2001171) (positive regulation of ATP biosynthetic process), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0002755](http://purl.obolibrary.org/obo/GO_0002755) (MyD88-dependent toll-like receptor signaling pathway), [GO:0019087](http://purl.obolibrary.org/obo/GO_0019087) (transformation of host cell by virus), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0005121](http://purl.obolibrary.org/obo/GO_0005121) (Toll binding), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0043085](http://purl.obolibrary.org/obo/GO_0043085) (positive regulation of catalytic activity), [GO:0070555](http://purl.obolibrary.org/obo/GO_0070555) (response to interleukin-1), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0045821](http://purl.obolibrary.org/obo/GO_0045821) (positive regulation of glycolytic process), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0000320](http://purl.obolibrary.org/obo/GO_0000320) (re-entry into mitotic cell cycle), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0010918](http://purl.obolibrary.org/obo/GO_0010918) (positive regulation of mitochondrial membrane potential), [GO:1902622](http://purl.obolibrary.org/obo/GO_1902622) (regulation of neutrophil migration), [GO:1901532](http://purl.obolibrary.org/obo/GO_1901532) (regulation of hematopoietic progenitor cell differentiation), [GO:1901534](http://purl.obolibrary.org/obo/GO_1901534) (positive regulation of hematopoietic progenitor cell differentiation), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0001783](http://purl.obolibrary.org/obo/GO_0001783) (B cell apoptotic process), [GO:0044195](http://purl.obolibrary.org/obo/GO_0044195) (nucleoplasmic reticulum), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0001658](http://purl.obolibrary.org/obo/GO_0001658) (branching involved in ureteric bud morphogenesis), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0043388](http://purl.obolibrary.org/obo/GO_0043388) (positive regulation of DNA binding), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0035914](http://purl.obolibrary.org/obo/GO_0035914) (skeletal muscle cell differentiation), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0033613](http://purl.obolibrary.org/obo/GO_0033613) (activating transcription factor binding), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:0043279](http://purl.obolibrary.org/obo/GO_0043279) (response to alkaloid), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0021987](http://purl.obolibrary.org/obo/GO_0021987) (cerebral cortex development), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0007346](http://purl.obolibrary.org/obo/GO_0007346) (regulation of mitotic cell cycle), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0051573](http://purl.obolibrary.org/obo/GO_0051573) (negative regulation of histone H3-K9 methylation), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin), [GO:0032755](http://purl.obolibrary.org/obo/GO_0032755) (positive regulation of interleukin-6 production), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0043049](http://purl.obolibrary.org/obo/GO_0043049) (otic placode formation), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:2000338](http://purl.obolibrary.org/obo/GO_2000338) (regulation of chemokine (C-X-C motif) ligand 1 production), [GO:0032747](http://purl.obolibrary.org/obo/GO_0032747) (positive regulation of interleukin-23 production), [GO:0071074](http://purl.obolibrary.org/obo/GO_0071074) (eukaryotic initiation factor eIF2 binding), [GO:0045351](http://purl.obolibrary.org/obo/GO_0045351) (type I interferon biosynthetic process), [GO:0032740](http://purl.obolibrary.org/obo/GO_0032740) (positive regulation of interleukin-17 production), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0032986](http://purl.obolibrary.org/obo/GO_0032986) (protein-DNA complex disassembly), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0035457](http://purl.obolibrary.org/obo/GO_0035457) (cellular response to interferon-alpha), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0035690](http://purl.obolibrary.org/obo/GO_0035690) (cellular response to drug), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0006352](http://purl.obolibrary.org/obo/GO_0006352) (DNA-templated transcription, initiation), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0005149](http://purl.obolibrary.org/obo/GO_0005149) (interleukin-1 receptor binding), [GO:1901857](http://purl.obolibrary.org/obo/GO_1901857) (positive regulation of cellular respiration), [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:2000341](http://purl.obolibrary.org/obo/GO_2000341) (regulation of chemokine (C-X-C motif) ligand 2 production), [GO:0035325](http://purl.obolibrary.org/obo/GO_0035325) (Toll-like receptor binding), 

**Class expressions from DL-Learner:**

- Thing 54.91%
- [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium) 50.85%
- [GO:0044195](http://purl.obolibrary.org/obo/GO_0044195) (nucleoplasmic reticulum) 50.85%
- [GO:0009682](http://purl.obolibrary.org/obo/GO_0009682) (induced systemic resistance) 50.85%
- [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum) 50.85%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 50.85%
- [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin) 50.85%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 50.85%
- [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope) 50.85%
- [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center) 50.85%
- [GO:0000791](http://purl.obolibrary.org/obo/GO_0000791) (euchromatin) 50.85%
- [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium) and [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response) 50.85%
- [GO:0031975](http://purl.obolibrary.org/obo/GO_0031975) (envelope) and [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 50.85%
- [GO:0031967](http://purl.obolibrary.org/obo/GO_0031967) (organelle envelope) and [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 50.85%
- [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) and [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response) 50.85%


